Company: KVACU
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0001213900-25-021314
Chunk: 653

Company: Keen Vision Acquisition Corp.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 6
Chunk 653
---

    Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Alliance (GBABA)
     
    Founder and Chairman

    Hong Kong Biotechnology Organization (HKBIO)
     
    Founder and Chairman

    Glia and Neuro-diseases Committee of Beijing Society for Neuroscience (BJSN)
     
    Director

    Oversight Committee of the Sino-International Institute of Translation Medicine at Shenzhen (SIITM)
     
    Committee Member

    National Institute of Metrology,
 China (Bio-Related)
     
    Advisor

    Biotech Advisory Panel of the Stock Exchange of Hong Kong Limited (HKEX)
     
    Panel member

    Gordon Research Conferences
     
    Board of Trustees

    Asia Fund for Cancer Research Foundation (AFCR)
     
    Director

    The Hong Kong Chinese Importers’ & Exporters’ Association
     
    Director

    BIOHK Ltd.
     
    Director

    SUN YAT-SEN Cultural Foundation Ltd.
     
    Director

    H.K. Life Publishing Ltd.
     
    Director

    Hong Kong DNA Chips Ltd.
     
    Director

    Angenomics Ltd.
     
    Director

    DNA-Tech Ltd.
     
    Director

    Hong Kong-Taiwan Youth Exchange Association Ltd.
     
    Director

    The Food Safety Laboratories Limited
     
    Director

    Jin Dong Company Ltd.
     
    Director

36

In connection with the vote
required for any initial business combination, all of our existing shareholders, including all of our officers and directors, have agreed
to vote their respective insider shares and private shares in favor of any proposed initial business combination. In addition, they have
agreed to waive their respective rights to participate in any liquidation distribution with respect to those ordinary shares acquired
by them prior to this offering. However. if they purchase ordinary shares in this offering or in the open market, they would be entitled
to participate in any liquidation distribution in respect of such shares but have agreed not to convert such shares (or sell their shares
in any tender offer) in connection with the consummation of our initial business combination or an amendment to our amended and restated
memorandum and articles of association relating to pre-business combination activity.

All ongoing and future transactions
between us and any of our officers and directors or their respective affiliates will be on terms believed by us to be no less favorable